跳至主要内容
临床试验/JPRN-UMIN000009064
JPRN-UMIN000009064已完成未知

A study to evaluate the safety and efficacy of tolvaptan in HF patients who undergo cardiac angiography - A study to evaluate the safety and efficacy of tolvaptan in HF patients who undergo cardiac angiography

Showa University Northern Yokohama Hospital0 个研究点目标入组 40 人开始时间: 2012年10月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)history of allergy against this drug or similar compounds (2)anuria (urine volume <100ml/day) (3)subjects who cannot feel thirsty or have difficulty to drink (4)subjects whose serum sodium level is over 147mEq/L (5)subjects who are pregnant or possibly pregnant (6)subjects who already have tolvaptan at the entry (7)acute coronary syndrome (8)patients who are judged to be inappropriate to this study

研究者

发起方
Showa University Northern Yokohama Hospital

相似试验